Distributor inventory | Tablet
Teneligliptin 20 mg + Metformin Hydrochloride 1000 mg (Prolonged/Extended Release, if specified on pack)
Type 2 diabetes mellitus to improve blood glucose control along with diet and exercise, especially when control is inadequate with metformin alone or combination therapy is required
Teneligliptin is a DPP-4 inhibitor that increases incretin levels (GLP-1, GIP), thereby increasing insulin release and decreasing glucagon in a glucose-dependent manner. Metformin decreases hepatic glucose production and improves peripheral insulin sensitivity, reducing blood glucose levels.
Take by mouth exactly as prescribed. Usually taken once daily with food (preferably with evening meal) to reduce stomach upset; if it is an extended-release tablet, swallow whole—do not crush/chew/split. Monitor blood glucose regularly.
Common side effects of ZITAMET 20/1000 TAB may include:
Prescription-only antidiabetic. Metformin may rarely cause lactic acidosis—risk increases with kidney impairment, dehydration, severe infection, alcohol use, heart/liver failure; assess renal function before and during therapy. Avoid/use with caution in severe renal impairment; temporarily stop around iodinated contrast procedures and major surgery as advised. DPP-4 inhibitors can rarely cause pancreatitis or severe joint pain; seek medical help for severe abdominal pain. Not for type 1 diabetes or diabetic ketoacidosis.
